Study details
Enrolling now
A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
BioLab Holdings
NCT IDNCT07364630ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
50
Study length
about 1.1 years
Ages
18+
Locations
1 site in PA
About this study
This trial is testing different treatments for nonhealing diabetic foot ulcers and venous leg ulcers. It compares human placental membrane products with standard care, along with various wrap types, to see which works best.
Based on ClinicalTrials.gov records.
What participants do
- 1.Membrane Wrap-Hydro™ DFU
- 2.Membrane Wrap-Hydro™ VLU
- 3.Membrane Wrap-Lite™ DFU
- +3 more
PhasePhase 4
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low11%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Adverse Events, Determine improvement in Quality of Life, Pain in patients who present with VAS greater than 4, Time to Closure